Physician profile
Tamara Wiggins
NPI 1255924502
$1,709.78
in general payments reported to CMS, 2019-2025
15 companies · $83.69 in 2025
The $83.69 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,345 · 2023: $55.93 · 2024: $225 · 2025: $83.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,218.37 | 2021 | |
| Boston Scientific Corporation | $126.17 | 2021-2024 | |
| Astellas Pharma US INC | $74.61 | 2024-2025 | Xtandi |
| Dendreon Pharmaceuticals LLC | $50.91 | 2024 | Provenge |
| Karl Storz Endoscopy-America | $32.30 | 2024 | Hopkins |
| Coloplast Corp | $31.04 | 2023-2024 | Speedicath |
| Teleflex LLC | $24.37 | 2025 | Barrigel |
| Myriad Genetic Laboratories, INC. | $22.65 | 2025 | Prolaris |
| Endo USA, INC. | $22.62 | 2024 | Xiaflex |
| 180 Medical, INC. | $20.80 | 2023 | Cure Catheter |
| Pfizer INC. | $19.55 | 2024 | |
| Janssen Biotech, INC. | $19.14 | 2023 | Erleada |
| Medtronic, INC. | $18.00 | 2021 | |
| Sumitomo Pharma America, INC. | $15.88 | 2025 | Gemtesa |
| Procept Biorobotics Corporation | $13.37 | 2024 | Aquabeam System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Wiggins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.